General factors influencing drug delivery to the lung

Respiratory Medicine

Volumn 91, Issue SUPPL. A, 1997, Pages 13-16

  Ganderton, D ^a,b  

^a Medicines and Healthcare Products Regulatory Agency   (United Kingdom)

^b Cheriton Bishop   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; DRUG CARRIER; INSULIN; TERBUTALINE;

ASTHMA; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRY POWDER; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION; INHALATIONAL DRUG ADMINISTRATION; LUNG; METERED DOSE INHALER; POWDER INHALER; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030707638     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90099-8     Document Type: Article

References (5)

1. Auty RM, Brown K, Neale MG, Snashall PD. Respiratory tract deposition of sodium cromoglycate is highly dependent upon the techniques of inhalation using the Spinhaler. Br J Dis Chest 1987; 81: 415-420.
2. Pedersen S, Hansen OR, Fugslang G. Influence of inspiratory rate upon the effect of a Turbuhaler. Arch Dis Child 1990; 65: 308-311.
3. Borgström L, Derom E, Stähl E, Wählin-Bull E, Pauwels R. The inhalation device influences lung deposition and bronchodilating effect of terbutaline. Am J Respir Crit Care Med 1996; 153: 1436-1440.
4. Colthorpe P, Farr SJ, Taylor G, et al. The pharmacokinetics of pulmonary-delivered insulin: a comparison of intratracheal and aerosol administration to the rabbit. Pharm Res 1992; 9: 764-768.
5. Pillai RS, Hughes BL, Wolff RK, et al. The effect of pulmonary-delivered insulin on blood glucose levels using two nebulizer systems. J Aerosol Med 1996; 9: 227-240.